ResMed, F. Hoffmann-La Roche and Boston Scientific Corporation are Dominating the U.S. Remote Patient Monitoring and Care Market in 2020

U.S. Remote Patient Monitoring and Care Market is expected to grow with the CAGR of 31.4% in the forecast period of 2021 to 2028. The years considered for study are as mentioned below.

Access Full Report @ https://www.databridgemarketresearch.com/reports/us-remote-patient-monitoring-and-care-market

U.S. remote patient monitoring and care market is a highly consolidated market, which includes specific number of key players. The market has witnessed increasing development of advanced products owing to favourable market scenario.   

The major players dealing in the U.S. remote patient monitoring and care market are introducing are expanding their production capacities, launching new companies, and adopting strategic initiative such as acquisition, agreement, business expansion, award and recognition into the market. This helped companies to maximize the sales with enhanced product portfolio.

For instance:

  • In April 2021, General Electric Company announced its collaboration with Verizon Business to create a cross-country testbed powered by Verizon 5G ultra-wide band. This collaboration dawn a new era for smart industrial machines and systems and has explored energy, healthcare and aviation use cases. This has helped the company to improve its product portfolio by delivering new technology.

ResMed is the dominating player in the U.S remote patient monitoring and care market. The other key players existing in the market includes Abbott, Medtronic, Boston Scientific Corporation, Wipro Limited, Resideo Technologies Inc., Neoteryx, LLC, Vivify Health, Inc., Koninklijke Philips N.V., Cardiomo, Huma, Welkin Health, Care Innovations, LLC (A Subsidiary of Pharmaceutical Research Associates Inc.), AlayaCare, General Electric, Datos Ltd., ResMed, Orion Health Group of Companies, and F. Hoffmann-La Roche Ltd, Limited among other players.

U.S. Remote Patient Monitoring and Care Market

ResMed

ResMed is headquartered in California, U.S.A., was founded in 1989. The company is mainly focused towards improving every breath by its offering to treat sleep apnea, CAPD, COPD and other respiratory diseases. The company deals in mask & devices, titration business segments.

  • In November 2020, ResMed had expanded its product portfolio with the addition of new remote patient monitoring to its existing respiratory product portfolio. The introduction of new products has allowed the company to provide patient with an ease to monitor breathing rate and to achieve better medication at correct time. This expansion helped the company to generate more revenue potential in the market.

The company has wide presence across Americas, Asia, Europe, Middle East and Africa.

F.Hoffmann-La Roche

F.Hoffmann-La Roche is headquartered in Basel, Switzerland, was founded in 1896. The company is focused on fitting treatment to patients and providing the right therapy for the group of patient. The company is exclusively concentrating on ophthalmology, diabetes and oncology division.

  • In April 2021, F. Hoffmann-La Roche Ltd announced that it purchased share in tender offer for GenMark Diagnostics, Inc. Roche intends to complete the acquisition of GenMark through a merger of Geronimo Acquisition Corp. with and into GenMark without a vote or meeting of GenMark’s stockholders. This has helped the company to expand its business.

The company has wide presence across North America, Asia, Europe, Middle East and Africa. The company also have various subsidiary companies such as Productos Roche S.A (Colombia), Roche Diabetes Care France SAS (France), Roche Georgia LLC (Georgia), and Roche Pharmaceuticals (Israel) Ltd. (Israel), among others.

Boston Scientific Corporation

Boston Scientific Corporation is headquartered in Massachusetts, U.S., was founded in 1893.The company focuses on transforming lives through innovative medical solutions that improve the health of patients around the world.

  • In December 2020, Boston Scientific Corporation announced the launch of LATITUDE NXT 7.0 software. This software enable the user to have following features such as MRI protection that even counts diagnostic on the Summary page and applicable reports and MRI Summary Report will be available in the arrhythmia log book. This software release has helped to have better patient compliance.

The company has wide presence across Americas, Asia, Europe, Middle East and Africa. The company also have various subsidiary companies such as Acurate Industria e Comercio Ltda (Brazil), American Medical Systems Europe B.V (Netherlands), Apama Medical Inc (U.S), and Augmenix Inc (U.S) among others.